68463-9
Rilpivirine [Susceptibility] by Genotype method
Active
Term Description
This test refers to sequence-based genotyping of HIV in human plasma infected with the virus to identify genotypic resistance to Rilpivirine. The assay involves the isolation of HIV RNA from blood plasma and amplification of the protease and reverse transcriptase genes. The PCR product is sequenced and analyzed. Genotypic characteristics of the virus are used to predict resistance to Rilipvirine.
Source: Regenstrief LOINC
Part Description
LP135443-2 Rilpivirine
Rilpivirine (brand name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, http://en.wikipedia.org/wiki/Rilpivirine
Fully-Specified Name
- Component
- Rilpivirine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- Ord
- Method
- Genotyping
Additional Names
- Short Name
- Rilpivirine Islt Genotyp
- Display Name
- Rilpivirine Genotyping [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rilpivirine
Example Answer List: LL1908-4
Source: LOINC partner 1Answer | Code | Score | Answer ID |
---|---|---|---|
Sensitive | LA16549-0 | ||
Resistant | LA6676-6 | ||
Resistance possible | LA17970-7 |
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.38
- Last Updated
- Version 2.73
- Change Reason
- Corrected Scale from OrdQn to Ord because Genotyping does not produce a quantitative susceptibility result
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 10946
Member of these Panels
LOINC | Long Common Name |
---|---|
49660-4 | HIV susceptibility panel by Genotype method |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG41382-9 | RilpivirineSusc| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Rilpivirina: |
es-MX | Spanish (Mexico) | Rilpivirina: |
fr-CA | French (Canada) | Rilpivirine: |
fr-FR | French (France) | Rilpivirine: |
it-IT | Italian (Italy) | Rilpivirina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità al genotipo virale |
nl-NL | Dutch (Netherlands) | rilpivirine: |
ru-RU | Russian (Russian Federation) | Рилпивирин: Synonyms: Вирусного генотипа чувствительность Порядковый Точка во времени; |
tr-TR | Turkish (Turkey) | Rilpivirin: |
zh-CN | Chinese (China) | 利匹韦林: Synonyms: 4-[4-[4-[(E)-2-Cyanovinyl]-2,6-dimethylphenylamino]pyrimidin-2-ylamino]benzonitrile; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=68463-9
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright